OR WAIT null SECS
April 09, 2025
Article
An analysis of data from 2 PBC and PSC cohorts suggests fatigue is common, especially in females with PBC, and may be influenced by pruritus.
April 08, 2025
Scoping review results suggest AUD medications may improve hepatic outcomes in patients with ALD, but limited research exists on such an association.
April 07, 2025
Study findings suggest use and monitoring of commonly evaluated hepatic biomarkers and fibrosis scores may provide additional prognostic value in PBC.
April 04, 2025
Our Q1 recap for hepatology spotlights regulatory updates, clinical trial data, 2 new guidance documents, and the anniversary of a historic FDA approval.
April 03, 2025
PBC patients with increased serum IgG levels at initial evaluation experienced faster disease progression and a greater probability of liver-related death.
April 02, 2025
Bariatric surgery was associated with improved overall survival at an acceptable health care cost within a 10-year horizon.
April 01, 2025
The month in review spotlights coverage of the anniversary of resmetirom’s FDA approval and research in autoimmune hepatitis, HBV vaccination, and MASLD.
March 31, 2025
Video
Mantzoros explains the need for multidisciplinary MASLD care and how to balance lifestyle modifications with emerging medications.
Kwo describes different barriers to hepatitis A and B vaccination for people with liver disease and looks ahead to future innovations and novel strategies.
March 28, 2025
Mantzoros explains factors contributing to the growing burden of MASLD and the need for collaboration between hepatology, primary care, and endocrinology.
